Tandem Diabetes Care, Inc. (TNDM) 10-Year Financial Performance & Capital Metrics

TNDM • • Industrial / General

HealthcareMedical DevicesDiabetes & Metabolic DevicesContinuous Glucose Monitoring

AboutTandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.Show more

Revenue $940M +25.7%
EBITDA -$99M +54.5%
Net Income -$96M +56.9%
EPS (Diluted) -1.47 +57.1%
Gross Margin 52.07% +5.9%
EBITDA Margin -10.53% +63.8%
Operating Margin -10.54% +66.2%
Net Margin -10.21% +65.7%
ROE -33.3% +43.6%
ROIC -11.11% +56.9%
Debt/Equity 1.80 +35.8%
Interest Coverage -13.37 +43.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 21.0%

✗Weaknesses

✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y34.17%

5Y21.01%

3Y10.19%

TTM3.42%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-60.41%

EPS CAGR

10Y-

5Y-

3Y-

TTM-57.96%

ROCE

10Y Avg-35.61%

5Y Avg-10.32%

3Y Avg-17.65%

Latest-13.41%

Peer Comparison

Continuous Glucose Monitoring

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PODDInsulet Corporation	20.15B	286.49	49.57	22.07%	9.76%	17.79%	1.52%	1.17
DXCMDexCom, Inc.	27B	69.24	48.76	11.34%	15.96%	26.44%	2.34%	1.23
AHCOAdaptHealth Corp.	1.44B	10.64	17.44	1.9%	2.81%	4.93%	16.36%	1.35
MODDModular Medical, Inc.	36.82M	0.47	-0.93			-276.23%		0.05
SENSSenseonics Holdings, Inc.	297.04M	7.27	-2.91	0.37%	-209.21%	-82.83%
TNDMTandem Diabetes Care, Inc.	1.43B	21.07	-14.33	25.74%	-20.2%	-152.95%	0.35%	1.80

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	72.85M	84.25M	107.6M	183.87M	362.31M	498.83M	702.8M	801.22M	747.72M	940.2M
Revenue Growth %	0.47%	0.16%	0.28%	0.71%	0.97%	0.38%	0.41%	0.14%	-0.07%	0.26%
Cost of Goods Sold+	46.27M	60.66M	63.51M	94.04M	168.09M	238.31M	326.58M	388.23M	380.03M	450.63M
COGS % of Revenue	0.64%	0.72%	0.59%	0.51%	0.46%	0.48%	0.46%	0.48%	0.51%	0.48%
Gross Profit+	26.58M	23.59M	44.09M	89.82M	194.21M	260.52M	376.21M	412.99M	367.69M	489.57M
Gross Margin %	0.36%	0.28%	0.41%	0.49%	0.54%	0.52%	0.54%	0.52%	0.49%	0.52%
Gross Profit Growth %	0.74%	-0.11%	0.87%	1.04%	1.16%	0.34%	0.44%	0.1%	-0.11%	0.33%
Operating Expenses+	95.58M	101.64M	107.04M	134.45M	210.93M	268.48M	353.56M	505.83M	600.92M	588.7M
OpEx % of Revenue	1.31%	1.21%	0.99%	0.73%	0.58%	0.54%	0.5%	0.63%	0.8%	0.63%
Selling, General & Admin	78.62M	82.83M	86.38M	105.23M	165.74M	204.9M	261.51M	335.68M	352.5M	389.82M
SG&A % of Revenue	1.08%	0.98%	0.8%	0.57%	0.46%	0.41%	0.37%	0.42%	0.47%	0.41%
Research & Development	16.96M	18.81M	20.66M	29.23M	45.2M	63.57M	92.05M	170.15M	248.42M	198.88M
R&D % of Revenue	0.23%	0.22%	0.19%	0.16%	0.12%	0.13%	0.13%	0.21%	0.33%	0.21%
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income+	-69M	-78.05M	-62.94M	-44.63M	-16.72M	-7.96M	22.65M	-92.85M	-233.23M	-99.13M
Operating Margin %	-0.95%	-0.93%	-0.58%	-0.24%	-0.05%	-0.02%	0.03%	-0.12%	-0.31%	-0.11%
Operating Income Growth %	0.09%	-0.13%	0.19%	0.29%	0.63%	0.52%	3.85%	-5.1%	-1.51%	0.57%
EBITDA+	-64.17M	-72.56M	-56.08M	-38.81M	-10.65M	2.49M	36.5M	-78.52M	-217.51M	-98.97M
EBITDA Margin %	-0.88%	-0.86%	-0.52%	-0.21%	-0.03%	0.01%	0.05%	-0.1%	-0.29%	-0.11%
EBITDA Growth %	0.1%	-0.13%	0.23%	0.31%	0.73%	1.23%	13.63%	-3.15%	-1.77%	0.55%
D&A (Non-Cash Add-back)	4.83M	5.49M	6.87M	5.82M	6.07M	10.45M	13.85M	14.33M	15.71M	158K
EBIT	-68.67M	-77.75M	-61.68M	-115M	-24.53M	-23.48M	20.21M	-88.54M	-212.18M	-99.28M
Net Interest Income+	-3.4M	-5.41M	-11.1M	-6.12M	3.19M	-11.24M	-5.37M	-151K	12.98M	10.58M
Interest Income	337K	296K	239K	1.46M	3.27M	1.57M	674K	6.06M	22.86M	17.99M
Interest Expense	3.74M	5.71M	11.34M	7.58M	78K	12.8M	6.04M	6.21M	9.88M	7.42M
Other Income/Expense	-3.4M	-5.41M	-10.08M	-77.93M	-7.88M	-28.32M	-6.75M	-4K	12.98M	7.26M
Pretax Income+	-72.41M	-83.46M	-73.03M	-122.56M	-24.6M	-36.28M	15.9M	-92.85M	-220.25M	-91.87M
Pretax Margin %	-0.99%	-0.99%	-0.68%	-0.67%	-0.07%	-0.07%	0.02%	-0.12%	-0.29%	-0.1%
Income Tax+	10K	-15K	8K	51K	149K	-1.9M	335K	1.74M	2.36M	4.16M
Effective Tax Rate %	1%	1%	1%	1%	1.01%	0.95%	0.98%	1.02%	1.01%	1.05%
Net Income+	-72.42M	-83.45M	-73.03M	-122.61M	-24.75M	-34.38M	15.57M	-94.59M	-222.61M	-96.03M
Net Margin %	-0.99%	-0.99%	-0.68%	-0.67%	-0.07%	-0.07%	0.02%	-0.12%	-0.3%	-0.1%
Net Income Growth %	0.09%	-0.15%	0.12%	-0.68%	0.8%	-0.39%	1.45%	-7.08%	-1.35%	0.57%
Net Income (Continuing)	-72.42M	-83.45M	-73.03M	-122.61M	-24.75M	-34.38M	15.57M	-94.59M	-222.61M	-96.03M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-25.04	-27.30	-12.86	-2.55	-0.42	-0.56	0.24	-1.47	-3.43	-1.47
EPS Growth %	0.27%	-0.09%	0.53%	0.8%	0.84%	-0.33%	1.43%	-7.13%	-1.33%	0.57%
EPS (Basic)	-25.04	-27.30	-12.86	-2.55	-0.42	-0.56	0.25	-1.47	-3.43	-1.47
Diluted Shares Outstanding	2.89M	3.06M	5.68M	48.13M	58.51M	60.99M	64.35M	64.15M	64.97M	65.45M
Basic Shares Outstanding	2.89M	3.06M	5.68M	48.13M	58.51M	60.99M	63M	64.15M	64.9M	65.45M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	106.98M	92.09M	64.16M	187.88M	276.14M	637.24M	811.52M	849.98M	747.99M	724.49M
Cash & Short-Term Investments	71.11M	53.54M	14.18M	129.03M	176.46M	484.94M	623.81M	616.9M	467.91M	438.33M
Cash Only	43.09M	44.68M	13.7M	41.83M	51.17M	94.61M	71.18M	172.52M	58.87M	69.23M
Short-Term Investments	28.02M	8.86M	479K	87.2M	125.28M	390.32M	552.63M	444.38M	409.04M	369.1M
Accounts Receivable	14.05M	11.17M	20.79M	35.19M	46.59M	82.19M	110.72M	114.72M	105.56M	114.58M
Days Sales Outstanding	70.42	48.4	70.53	69.86	46.93	60.14	57.51	52.26	51.53	44.48
Inventory	17.54M	21.2M	26.99M	19.9M	49.07M	63.72M	68.55M	111.12M	157.94M	149.61M
Days Inventory Outstanding	138.39	127.54	155.14	77.22	106.56	97.6	76.61	104.47	151.69	121.18
Other Current Assets	2M	2M	2.19M	3.77M	0	0	0	7.24M	16.59M	21.96M
Total Non-Current Assets+	18.14M	20.3M	31.19M	18.41M	49.97M	79.18M	93.62M	202.81M	204.67M	243.17M
Property, Plant & Equipment	15.53M	18.41M	19.63M	17.15M	48.48M	69.8M	77.89M	179.18M	164.33M	163.46M
Fixed Asset Turnover	4.69x	4.58x	5.48x	10.72x	7.47x	7.15x	9.02x	4.47x	4.55x	5.75x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	2.11M	1.78M	1.46M	1.13M	777K	8.8M	6.64M	4.63M	2.78M	925K
Long-Term Investments	0	0	10M	0	0	0	0	0	0	74.55M
Other Non-Current Assets	499K	107K	10.1M	128K	708K	580K	9.09M	19M	37.56M	4.24M
Total Assets+	125.12M	112.39M	95.35M	206.29M	326.11M	716.41M	905.14M	1.05B	952.66M	967.66M
Asset Turnover	0.58x	0.75x	1.13x	0.89x	1.11x	0.70x	0.78x	0.76x	0.78x	0.97x
Asset Growth %	0.18%	-0.1%	-0.15%	1.16%	0.58%	1.2%	0.26%	0.16%	-0.1%	0.02%
Total Current Liabilities+	26.52M	31.48M	36.09M	66.29M	99.4M	103.85M	131.86M	165.29M	195.26M	247.05M
Accounts Payable	5.23M	7.51M	5.15M	6.82M	17.75M	17.8M	28.03M	55.73M	49.59M	44.73M
Days Payables Outstanding	41.29	45.21	29.6	26.48	38.53	27.27	31.33	52.4	47.63	36.23
Short-Term Debt	0	0	0	0	0	0	0	0	0	40.67M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	5.58M	8.57M	13.92M	30.83M	63.45M	65.76M	74.94M	68.01M	71.89M	47.08M
Current Ratio	4.03x	2.93x	1.78x	2.83x	2.78x	6.14x	6.15x	5.14x	3.83x	2.93x
Quick Ratio	3.37x	2.25x	1.03x	2.53x	2.28x	5.52x	5.63x	4.47x	3.02x	2.33x
Cash Conversion Cycle	167.52	130.73	196.07	120.6	114.96	130.47	102.79	104.33	155.59	129.44
Total Non-Current Liabilities+	35.13M	86.84M	88.41M	8.73M	31.73M	246.26M	340.17M	447.55M	443.77M	457.51M
Long-Term Debt	29.67M	78.96M	76.54M	0	0	202.98M	281.47M	283.23M	285.04M	308.27M
Capital Lease Obligations	0	0	0	0	14.06M	15.91M	23.92M	123.52M	113.57M	106.42M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	5.46M	7.88M	11.87M	8.73M	17.67M	27.36M	17.84M	23.92M	31.83M	32.37M
Total Liabilities	61.65M	118.32M	124.49M	75.02M	131.13M	350.11M	472.02M	612.84M	639.03M	704.56M
Total Debt+	29.67M	78.96M	76.54M	0	20.38M	228.32M	314.67M	419.88M	415.67M	473.56M
Net Debt	-13.42M	34.28M	62.84M	-41.83M	-30.79M	133.71M	243.49M	247.36M	356.8M	404.33M
Debt / Equity	0.47x	-	-	-	0.10x	0.62x	0.73x	0.95x	1.33x	1.80x
Debt / EBITDA	-	-	-	-	-	91.55x	8.62x	-	-	-
Net Debt / EBITDA	-	-	-	-	-	53.61x	6.67x	-	-	-
Interest Coverage	-18.45x	-13.68x	-5.55x	-5.88x	-214.38x	-0.62x	3.75x	-14.96x	-23.60x	-13.37x
Total Equity+	63.47M	-5.93M	-29.15M	131.28M	194.98M	366.31M	433.11M	439.95M	313.63M	263.1M
Equity Growth %	0.16%	-1.09%	-3.92%	5.5%	0.49%	0.88%	0.18%	0.02%	-0.29%	-0.16%
Book Value per Share	21.95	-1.94	-5.13	2.73	3.33	6.01	6.73	6.86	4.83	4.02
Total Shareholders' Equity	63.47M	-5.93M	-29.15M	131.28M	194.98M	366.31M	433.11M	439.95M	313.63M	263.1M
Common Stock	30K	31K	10K	57K	59K	62K	64K	65K	66K	66K
Retained Earnings	-321.13M	-404.58M	-477.61M	-600.08M	-624.83M	-659.21M	-634.6M	-729.19M	-951.8M	-1.05B
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	20K	-1K	0	-13K	122K	220K	-616K	-1.82M	1.37M	-1.95M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-58.76M	-61.17M	-66.14M	-8.32M	41.91M	24.67M	111.36M	50.46M	-31.81M	24.23M
Operating CF Margin %	-0.81%	-0.73%	-0.61%	-0.05%	0.12%	0.05%	0.16%	0.06%	-0.04%	0.03%
Operating CF Growth %	0.04%	-0.04%	-0.08%	0.87%	6.04%	-0.41%	3.51%	-0.55%	-1.63%	1.76%
Net Income	-72.42M	-83.45M	-73.03M	-122.61M	-24.75M	-34.38M	15.57M	-94.59M	-222.61M	-96.03M
Depreciation & Amortization	4.83M	5.49M	6.87M	5.82M	6.07M	10.45M	13.85M	14.33M	15.71M	16.61M
Stock-Based Compensation	13.1M	11.66M	12.63M	23.74M	58.07M	58.43M	60.75M	0	88.08M	0
Deferred Taxes	478K	3.89M	-187K	0	-25K	-2.13M	0	0	0	0
Other Non-Cash Items	215K	1.12M	3.7M	76.27M	14.89M	28.88M	6.82M	135.38M	104.69M	115.42M
Working Capital Changes	-4.96M	112K	-16.11M	8.46M	-12.35M	-36.59M	14.37M	-4.65M	-17.68M	-11.78M
Change in Receivables	-6.47M	2.25M	-10.45M	-15.85M	-13.7M	-38.84M	-30.98M	-7.83M	4.28M	-20.8M
Change in Inventory	-6.08M	-6.9M	-5.89M	6.76M	-30.98M	-15.36M	-4.95M	-42.45M	-46.05M	5.81M
Change in Payables	3.35M	3.23M	-1.95M	1.64M	8.91M	1.12M	10.28M	24.49M	-4.86M	-2.39M
Cash from Investing+	2.42M	10.45M	2.78M	-90.74M	-56.95M	-296.06M	-186.88M	33.17M	-85.74M	-23.48M
Capital Expenditures	-5.84M	-8.93M	-5.72M	-2.99M	-19.54M	-27.41M	-14.18M	-34.1M	-26.8M	-19.23M
CapEx % of Revenue	0.08%	0.11%	0.05%	0.02%	0.05%	0.05%	0.02%	0.04%	0.04%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-74K	10.46M	8.5M	-1.71M	0	-4.89M	-9.33M	-8.86M	0	-46.4M
Cash from Financing+	68.25M	52.31M	32.38M	117.18M	24.21M	314.44M	51.93M	16.88M	4.11M	8.37M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	0	2.32M	-8M	31.97M	24.21M	35.75M	51.93M	-675K	4.11M	183K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-64.6M	-70.1M	-71.85M	-11.3M	22.36M	-7.63M	87.85M	16.37M	-58.61M	4.99M
FCF Margin %	-0.89%	-0.83%	-0.67%	-0.06%	0.06%	-0.02%	0.12%	0.02%	-0.08%	0.01%
FCF Growth %	0.02%	-0.09%	-0.02%	0.84%	2.98%	-1.34%	12.52%	-0.81%	-4.58%	1.09%
FCF per Share	-22.34	-22.93	-12.66	-0.23	0.38	-0.13	1.37	0.26	-0.90	0.08
FCF Conversion (FCF/Net Income)	0.81x	0.73x	0.91x	0.07x	-1.69x	-0.72x	7.15x	-0.53x	0.14x	-0.25x
Interest Paid	3.35M	4.4M	7.88M	10.8M	0	2.71M	4.31M	0	7.57M	0
Taxes Paid	9K	23K	22K	16K	67K	177K	260K	0	1.92M	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-122.7%	-290.04%	-	-240.11%	-15.17%	-12.25%	3.89%	-21.67%	-59.08%	-33.3%
Return on Invested Capital (ROIC)	-100.6%	-149.32%	-152.17%	-54.37%	-9.89%	-1.8%	2.89%	-10.21%	-25.77%	-11.11%
Gross Margin	36.49%	28%	40.98%	48.85%	53.6%	52.23%	53.53%	51.54%	49.18%	52.07%
Net Margin	-99.41%	-99.05%	-67.87%	-66.69%	-6.83%	-6.89%	2.21%	-11.81%	-29.77%	-10.21%
Debt / Equity	0.47x	-	-	-	0.10x	0.62x	0.73x	0.95x	1.33x	1.80x
Interest Coverage	-18.45x	-13.68x	-5.55x	-5.88x	-214.38x	-0.62x	3.75x	-14.96x	-23.60x	-13.37x
FCF Conversion	0.81x	0.73x	0.91x	0.07x	-1.69x	-0.72x	7.15x	-0.53x	0.14x	-0.25x
Revenue Growth	46.51%	15.65%	27.72%	70.88%	97.05%	37.68%	40.89%	14%	-6.68%	25.74%

Revenue by Segment

	2014	2015	2016	2017	2020	2021	2022	2023	2024
Supplies and Other	-	-	-	-	-	-	-	-	475.79M
Supplies and Other Growth	-	-	-	-	-	-	-	-	-
Pump	-	-	-	-	-	-	-	-	434.17M
Pump Growth	-	-	-	-	-	-	-	-	-
Connect Hosting Service	700K	1.1M	1.6M	2M	-	-	-	-	-
Connect Hosting Service Growth	-	57.14%	45.45%	25.00%	-	-	-	-	-

Revenue by Geography

	2014	2015	2016	2017	2020	2021	2022	2023	2024
UNITED STATES	-	-	-	-	415.68M	524.91M	588.76M	554.88M	672.68M
UNITED STATES Growth	-	-	-	-	-	26.28%	12.17%	-5.76%	21.23%
Non-US	-	-	-	-	83.15M	177.89M	212.45M	192.84M	267.52M
Non-US Growth	-	-	-	-	-	113.94%	19.43%	-9.23%	38.73%

Frequently Asked Questions

Growth & Financials

Tandem Diabetes Care, Inc. (TNDM) reported $1.01B in revenue for fiscal year 2024.

Tandem Diabetes Care, Inc. (TNDM) grew revenue by 25.7% over the past year. This is strong growth.

Tandem Diabetes Care, Inc. (TNDM) reported a net loss of $203.4M for fiscal year 2024.

Dividend & Returns

Tandem Diabetes Care, Inc. (TNDM) has a return on equity (ROE) of -33.3%. Negative ROE indicates the company is unprofitable.

Tandem Diabetes Care, Inc. (TNDM) had negative free cash flow of $25.1M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Tandem Diabetes Care, Inc. (TNDM) 10-Year Financial Performance & Capital Metrics

TNDM • • Industrial / General

HealthcareMedical DevicesDiabetes & Metabolic DevicesContinuous Glucose Monitoring

Revenue $940M +25.7%
EBITDA -$99M +54.5%
Net Income -$96M +56.9%
EPS (Diluted) -1.47 +57.1%
Gross Margin 52.07% +5.9%
EBITDA Margin -10.53% +63.8%
Operating Margin -10.54% +66.2%
Net Margin -10.21% +65.7%
ROE -33.3% +43.6%
ROIC -11.11% +56.9%
Debt/Equity 1.80 +35.8%
Interest Coverage -13.37 +43.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 21.0%

✗Weaknesses

✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y34.17%

5Y21.01%

3Y10.19%

TTM3.42%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-60.41%

EPS CAGR

10Y-

5Y-

3Y-

TTM-57.96%

ROCE

10Y Avg-35.61%

5Y Avg-10.32%

3Y Avg-17.65%

Latest-13.41%

Peer Comparison

Continuous Glucose Monitoring

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PODDInsulet Corporation	20.15B	286.49	49.57	22.07%	9.76%	17.79%	1.52%	1.17
DXCMDexCom, Inc.	27B	69.24	48.76	11.34%	15.96%	26.44%	2.34%	1.23
AHCOAdaptHealth Corp.	1.44B	10.64	17.44	1.9%	2.81%	4.93%	16.36%	1.35
MODDModular Medical, Inc.	36.82M	0.47	-0.93			-276.23%		0.05
SENSSenseonics Holdings, Inc.	297.04M	7.27	-2.91	0.37%	-209.21%	-82.83%
TNDMTandem Diabetes Care, Inc.	1.43B	21.07	-14.33	25.74%	-20.2%	-152.95%	0.35%	1.80

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	72.85M	84.25M	107.6M	183.87M	362.31M	498.83M	702.8M	801.22M	747.72M	940.2M
Revenue Growth %	0.47%	0.16%	0.28%	0.71%	0.97%	0.38%	0.41%	0.14%	-0.07%	0.26%
Cost of Goods Sold+	46.27M	60.66M	63.51M	94.04M	168.09M	238.31M	326.58M	388.23M	380.03M	450.63M
COGS % of Revenue	0.64%	0.72%	0.59%	0.51%	0.46%	0.48%	0.46%	0.48%	0.51%	0.48%
Gross Profit+	26.58M	23.59M	44.09M	89.82M	194.21M	260.52M	376.21M	412.99M	367.69M	489.57M
Gross Margin %	0.36%	0.28%	0.41%	0.49%	0.54%	0.52%	0.54%	0.52%	0.49%	0.52%
Gross Profit Growth %	0.74%	-0.11%	0.87%	1.04%	1.16%	0.34%	0.44%	0.1%	-0.11%	0.33%
Operating Expenses+	95.58M	101.64M	107.04M	134.45M	210.93M	268.48M	353.56M	505.83M	600.92M	588.7M
OpEx % of Revenue	1.31%	1.21%	0.99%	0.73%	0.58%	0.54%	0.5%	0.63%	0.8%	0.63%
Selling, General & Admin	78.62M	82.83M	86.38M	105.23M	165.74M	204.9M	261.51M	335.68M	352.5M	389.82M
SG&A % of Revenue	1.08%	0.98%	0.8%	0.57%	0.46%	0.41%	0.37%	0.42%	0.47%	0.41%
Research & Development	16.96M	18.81M	20.66M	29.23M	45.2M	63.57M	92.05M	170.15M	248.42M	198.88M
R&D % of Revenue	0.23%	0.22%	0.19%	0.16%	0.12%	0.13%	0.13%	0.21%	0.33%	0.21%
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income+	-69M	-78.05M	-62.94M	-44.63M	-16.72M	-7.96M	22.65M	-92.85M	-233.23M	-99.13M
Operating Margin %	-0.95%	-0.93%	-0.58%	-0.24%	-0.05%	-0.02%	0.03%	-0.12%	-0.31%	-0.11%
Operating Income Growth %	0.09%	-0.13%	0.19%	0.29%	0.63%	0.52%	3.85%	-5.1%	-1.51%	0.57%
EBITDA+	-64.17M	-72.56M	-56.08M	-38.81M	-10.65M	2.49M	36.5M	-78.52M	-217.51M	-98.97M
EBITDA Margin %	-0.88%	-0.86%	-0.52%	-0.21%	-0.03%	0.01%	0.05%	-0.1%	-0.29%	-0.11%
EBITDA Growth %	0.1%	-0.13%	0.23%	0.31%	0.73%	1.23%	13.63%	-3.15%	-1.77%	0.55%
D&A (Non-Cash Add-back)	4.83M	5.49M	6.87M	5.82M	6.07M	10.45M	13.85M	14.33M	15.71M	158K
EBIT	-68.67M	-77.75M	-61.68M	-115M	-24.53M	-23.48M	20.21M	-88.54M	-212.18M	-99.28M
Net Interest Income+	-3.4M	-5.41M	-11.1M	-6.12M	3.19M	-11.24M	-5.37M	-151K	12.98M	10.58M
Interest Income	337K	296K	239K	1.46M	3.27M	1.57M	674K	6.06M	22.86M	17.99M
Interest Expense	3.74M	5.71M	11.34M	7.58M	78K	12.8M	6.04M	6.21M	9.88M	7.42M
Other Income/Expense	-3.4M	-5.41M	-10.08M	-77.93M	-7.88M	-28.32M	-6.75M	-4K	12.98M	7.26M
Pretax Income+	-72.41M	-83.46M	-73.03M	-122.56M	-24.6M	-36.28M	15.9M	-92.85M	-220.25M	-91.87M
Pretax Margin %	-0.99%	-0.99%	-0.68%	-0.67%	-0.07%	-0.07%	0.02%	-0.12%	-0.29%	-0.1%
Income Tax+	10K	-15K	8K	51K	149K	-1.9M	335K	1.74M	2.36M	4.16M
Effective Tax Rate %	1%	1%	1%	1%	1.01%	0.95%	0.98%	1.02%	1.01%	1.05%
Net Income+	-72.42M	-83.45M	-73.03M	-122.61M	-24.75M	-34.38M	15.57M	-94.59M	-222.61M	-96.03M
Net Margin %	-0.99%	-0.99%	-0.68%	-0.67%	-0.07%	-0.07%	0.02%	-0.12%	-0.3%	-0.1%
Net Income Growth %	0.09%	-0.15%	0.12%	-0.68%	0.8%	-0.39%	1.45%	-7.08%	-1.35%	0.57%
Net Income (Continuing)	-72.42M	-83.45M	-73.03M	-122.61M	-24.75M	-34.38M	15.57M	-94.59M	-222.61M	-96.03M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-25.04	-27.30	-12.86	-2.55	-0.42	-0.56	0.24	-1.47	-3.43	-1.47
EPS Growth %	0.27%	-0.09%	0.53%	0.8%	0.84%	-0.33%	1.43%	-7.13%	-1.33%	0.57%
EPS (Basic)	-25.04	-27.30	-12.86	-2.55	-0.42	-0.56	0.25	-1.47	-3.43	-1.47
Diluted Shares Outstanding	2.89M	3.06M	5.68M	48.13M	58.51M	60.99M	64.35M	64.15M	64.97M	65.45M
Basic Shares Outstanding	2.89M	3.06M	5.68M	48.13M	58.51M	60.99M	63M	64.15M	64.9M	65.45M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	106.98M	92.09M	64.16M	187.88M	276.14M	637.24M	811.52M	849.98M	747.99M	724.49M
Cash & Short-Term Investments	71.11M	53.54M	14.18M	129.03M	176.46M	484.94M	623.81M	616.9M	467.91M	438.33M
Cash Only	43.09M	44.68M	13.7M	41.83M	51.17M	94.61M	71.18M	172.52M	58.87M	69.23M
Short-Term Investments	28.02M	8.86M	479K	87.2M	125.28M	390.32M	552.63M	444.38M	409.04M	369.1M
Accounts Receivable	14.05M	11.17M	20.79M	35.19M	46.59M	82.19M	110.72M	114.72M	105.56M	114.58M
Days Sales Outstanding	70.42	48.4	70.53	69.86	46.93	60.14	57.51	52.26	51.53	44.48
Inventory	17.54M	21.2M	26.99M	19.9M	49.07M	63.72M	68.55M	111.12M	157.94M	149.61M
Days Inventory Outstanding	138.39	127.54	155.14	77.22	106.56	97.6	76.61	104.47	151.69	121.18
Other Current Assets	2M	2M	2.19M	3.77M	0	0	0	7.24M	16.59M	21.96M
Total Non-Current Assets+	18.14M	20.3M	31.19M	18.41M	49.97M	79.18M	93.62M	202.81M	204.67M	243.17M
Property, Plant & Equipment	15.53M	18.41M	19.63M	17.15M	48.48M	69.8M	77.89M	179.18M	164.33M	163.46M
Fixed Asset Turnover	4.69x	4.58x	5.48x	10.72x	7.47x	7.15x	9.02x	4.47x	4.55x	5.75x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	2.11M	1.78M	1.46M	1.13M	777K	8.8M	6.64M	4.63M	2.78M	925K
Long-Term Investments	0	0	10M	0	0	0	0	0	0	74.55M
Other Non-Current Assets	499K	107K	10.1M	128K	708K	580K	9.09M	19M	37.56M	4.24M
Total Assets+	125.12M	112.39M	95.35M	206.29M	326.11M	716.41M	905.14M	1.05B	952.66M	967.66M
Asset Turnover	0.58x	0.75x	1.13x	0.89x	1.11x	0.70x	0.78x	0.76x	0.78x	0.97x
Asset Growth %	0.18%	-0.1%	-0.15%	1.16%	0.58%	1.2%	0.26%	0.16%	-0.1%	0.02%
Total Current Liabilities+	26.52M	31.48M	36.09M	66.29M	99.4M	103.85M	131.86M	165.29M	195.26M	247.05M
Accounts Payable	5.23M	7.51M	5.15M	6.82M	17.75M	17.8M	28.03M	55.73M	49.59M	44.73M
Days Payables Outstanding	41.29	45.21	29.6	26.48	38.53	27.27	31.33	52.4	47.63	36.23
Short-Term Debt	0	0	0	0	0	0	0	0	0	40.67M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	5.58M	8.57M	13.92M	30.83M	63.45M	65.76M	74.94M	68.01M	71.89M	47.08M
Current Ratio	4.03x	2.93x	1.78x	2.83x	2.78x	6.14x	6.15x	5.14x	3.83x	2.93x
Quick Ratio	3.37x	2.25x	1.03x	2.53x	2.28x	5.52x	5.63x	4.47x	3.02x	2.33x
Cash Conversion Cycle	167.52	130.73	196.07	120.6	114.96	130.47	102.79	104.33	155.59	129.44
Total Non-Current Liabilities+	35.13M	86.84M	88.41M	8.73M	31.73M	246.26M	340.17M	447.55M	443.77M	457.51M
Long-Term Debt	29.67M	78.96M	76.54M	0	0	202.98M	281.47M	283.23M	285.04M	308.27M
Capital Lease Obligations	0	0	0	0	14.06M	15.91M	23.92M	123.52M	113.57M	106.42M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	5.46M	7.88M	11.87M	8.73M	17.67M	27.36M	17.84M	23.92M	31.83M	32.37M
Total Liabilities	61.65M	118.32M	124.49M	75.02M	131.13M	350.11M	472.02M	612.84M	639.03M	704.56M
Total Debt+	29.67M	78.96M	76.54M	0	20.38M	228.32M	314.67M	419.88M	415.67M	473.56M
Net Debt	-13.42M	34.28M	62.84M	-41.83M	-30.79M	133.71M	243.49M	247.36M	356.8M	404.33M
Debt / Equity	0.47x	-	-	-	0.10x	0.62x	0.73x	0.95x	1.33x	1.80x
Debt / EBITDA	-	-	-	-	-	91.55x	8.62x	-	-	-
Net Debt / EBITDA	-	-	-	-	-	53.61x	6.67x	-	-	-
Interest Coverage	-18.45x	-13.68x	-5.55x	-5.88x	-214.38x	-0.62x	3.75x	-14.96x	-23.60x	-13.37x
Total Equity+	63.47M	-5.93M	-29.15M	131.28M	194.98M	366.31M	433.11M	439.95M	313.63M	263.1M
Equity Growth %	0.16%	-1.09%	-3.92%	5.5%	0.49%	0.88%	0.18%	0.02%	-0.29%	-0.16%
Book Value per Share	21.95	-1.94	-5.13	2.73	3.33	6.01	6.73	6.86	4.83	4.02
Total Shareholders' Equity	63.47M	-5.93M	-29.15M	131.28M	194.98M	366.31M	433.11M	439.95M	313.63M	263.1M
Common Stock	30K	31K	10K	57K	59K	62K	64K	65K	66K	66K
Retained Earnings	-321.13M	-404.58M	-477.61M	-600.08M	-624.83M	-659.21M	-634.6M	-729.19M	-951.8M	-1.05B
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	20K	-1K	0	-13K	122K	220K	-616K	-1.82M	1.37M	-1.95M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-58.76M	-61.17M	-66.14M	-8.32M	41.91M	24.67M	111.36M	50.46M	-31.81M	24.23M
Operating CF Margin %	-0.81%	-0.73%	-0.61%	-0.05%	0.12%	0.05%	0.16%	0.06%	-0.04%	0.03%
Operating CF Growth %	0.04%	-0.04%	-0.08%	0.87%	6.04%	-0.41%	3.51%	-0.55%	-1.63%	1.76%
Net Income	-72.42M	-83.45M	-73.03M	-122.61M	-24.75M	-34.38M	15.57M	-94.59M	-222.61M	-96.03M
Depreciation & Amortization	4.83M	5.49M	6.87M	5.82M	6.07M	10.45M	13.85M	14.33M	15.71M	16.61M
Stock-Based Compensation	13.1M	11.66M	12.63M	23.74M	58.07M	58.43M	60.75M	0	88.08M	0
Deferred Taxes	478K	3.89M	-187K	0	-25K	-2.13M	0	0	0	0
Other Non-Cash Items	215K	1.12M	3.7M	76.27M	14.89M	28.88M	6.82M	135.38M	104.69M	115.42M
Working Capital Changes	-4.96M	112K	-16.11M	8.46M	-12.35M	-36.59M	14.37M	-4.65M	-17.68M	-11.78M
Change in Receivables	-6.47M	2.25M	-10.45M	-15.85M	-13.7M	-38.84M	-30.98M	-7.83M	4.28M	-20.8M
Change in Inventory	-6.08M	-6.9M	-5.89M	6.76M	-30.98M	-15.36M	-4.95M	-42.45M	-46.05M	5.81M
Change in Payables	3.35M	3.23M	-1.95M	1.64M	8.91M	1.12M	10.28M	24.49M	-4.86M	-2.39M
Cash from Investing+	2.42M	10.45M	2.78M	-90.74M	-56.95M	-296.06M	-186.88M	33.17M	-85.74M	-23.48M
Capital Expenditures	-5.84M	-8.93M	-5.72M	-2.99M	-19.54M	-27.41M	-14.18M	-34.1M	-26.8M	-19.23M
CapEx % of Revenue	0.08%	0.11%	0.05%	0.02%	0.05%	0.05%	0.02%	0.04%	0.04%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-74K	10.46M	8.5M	-1.71M	0	-4.89M	-9.33M	-8.86M	0	-46.4M
Cash from Financing+	68.25M	52.31M	32.38M	117.18M	24.21M	314.44M	51.93M	16.88M	4.11M	8.37M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	0	2.32M	-8M	31.97M	24.21M	35.75M	51.93M	-675K	4.11M	183K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-64.6M	-70.1M	-71.85M	-11.3M	22.36M	-7.63M	87.85M	16.37M	-58.61M	4.99M
FCF Margin %	-0.89%	-0.83%	-0.67%	-0.06%	0.06%	-0.02%	0.12%	0.02%	-0.08%	0.01%
FCF Growth %	0.02%	-0.09%	-0.02%	0.84%	2.98%	-1.34%	12.52%	-0.81%	-4.58%	1.09%
FCF per Share	-22.34	-22.93	-12.66	-0.23	0.38	-0.13	1.37	0.26	-0.90	0.08
FCF Conversion (FCF/Net Income)	0.81x	0.73x	0.91x	0.07x	-1.69x	-0.72x	7.15x	-0.53x	0.14x	-0.25x
Interest Paid	3.35M	4.4M	7.88M	10.8M	0	2.71M	4.31M	0	7.57M	0
Taxes Paid	9K	23K	22K	16K	67K	177K	260K	0	1.92M	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-122.7%	-290.04%	-	-240.11%	-15.17%	-12.25%	3.89%	-21.67%	-59.08%	-33.3%
Return on Invested Capital (ROIC)	-100.6%	-149.32%	-152.17%	-54.37%	-9.89%	-1.8%	2.89%	-10.21%	-25.77%	-11.11%
Gross Margin	36.49%	28%	40.98%	48.85%	53.6%	52.23%	53.53%	51.54%	49.18%	52.07%
Net Margin	-99.41%	-99.05%	-67.87%	-66.69%	-6.83%	-6.89%	2.21%	-11.81%	-29.77%	-10.21%
Debt / Equity	0.47x	-	-	-	0.10x	0.62x	0.73x	0.95x	1.33x	1.80x
Interest Coverage	-18.45x	-13.68x	-5.55x	-5.88x	-214.38x	-0.62x	3.75x	-14.96x	-23.60x	-13.37x
FCF Conversion	0.81x	0.73x	0.91x	0.07x	-1.69x	-0.72x	7.15x	-0.53x	0.14x	-0.25x
Revenue Growth	46.51%	15.65%	27.72%	70.88%	97.05%	37.68%	40.89%	14%	-6.68%	25.74%

Revenue by Segment

	2014	2015	2016	2017	2020	2021	2022	2023	2024
Supplies and Other	-	-	-	-	-	-	-	-	475.79M
Supplies and Other Growth	-	-	-	-	-	-	-	-	-
Pump	-	-	-	-	-	-	-	-	434.17M
Pump Growth	-	-	-	-	-	-	-	-	-
Connect Hosting Service	700K	1.1M	1.6M	2M	-	-	-	-	-
Connect Hosting Service Growth	-	57.14%	45.45%	25.00%	-	-	-	-	-

Revenue by Geography

	2014	2015	2016	2017	2020	2021	2022	2023	2024
UNITED STATES	-	-	-	-	415.68M	524.91M	588.76M	554.88M	672.68M
UNITED STATES Growth	-	-	-	-	-	26.28%	12.17%	-5.76%	21.23%
Non-US	-	-	-	-	83.15M	177.89M	212.45M	192.84M	267.52M
Non-US Growth	-	-	-	-	-	113.94%	19.43%	-9.23%	38.73%

Frequently Asked Questions

Growth & Financials

Tandem Diabetes Care, Inc. (TNDM) reported $1.01B in revenue for fiscal year 2024.

Tandem Diabetes Care, Inc. (TNDM) grew revenue by 25.7% over the past year. This is strong growth.

Tandem Diabetes Care, Inc. (TNDM) reported a net loss of $203.4M for fiscal year 2024.

Dividend & Returns

Tandem Diabetes Care, Inc. (TNDM) has a return on equity (ROE) of -33.3%. Negative ROE indicates the company is unprofitable.

Tandem Diabetes Care, Inc. (TNDM) had negative free cash flow of $25.1M in fiscal year 2024, likely due to heavy capital investments.